You are here

Pfizer

Pfizer's Next 3 Years: What Investors Can Expect

Motley Fool

Sun, 02/3/19 - 12:54 pm

EpiPens weren’t working. It took 3 years and the FDA stepping in before serious change — with potentially deadly outcomes

Business Insider

Sat, 02/2/19 - 12:41 pm

Meridian Medical Technologies

Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing

BioSpace

Fri, 02/1/19 - 11:27 am

FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game

Endpoints

Thu, 01/31/19 - 11:27 am

breakthrough status

Pfizer CEO: It'll be 2020 before issues in sterile injectables manufacturing are resolved

Fierce Pharma

Wed, 01/30/19 - 11:48 pm

drug manufacturing

Pfizer and Lilly’s tanezumab succeeds in second phase 3 osteoarthritis pain trial

Pharmaceutical Business Review

Wed, 01/30/19 - 10:05 am

clinical trials

osteoarthritis pain

3 Big Pharmas Expecting a Softer 2019

Motley Fool

Wed, 01/30/19 - 09:50 am

Pfizer Q4 Earnings Update: 4 Key Things You Need to Know

Motley Fool

Tue, 01/29/19 - 03:41 pm

As Pfizer kills failed PhIII programs for Bavencio, where do they go from here in R&D?

Endpoints

Tue, 01/29/19 - 10:02 am

Pfizer’s Cancer Portfolio Expected to Rake in $8.3 Billion in 2019

BioSpace

Mon, 01/28/19 - 10:44 pm

Based On Sales Forecasts For 2018 FDA Approved Drugs, Big Pharma Not Just Focused On Blockbusters

Forbes

Mon, 01/28/19 - 11:00 am

Gilead Sciences

Vertex Pharmaceuticals

3 Things You Should Expect in Pfizer's Q4 Earnings Update

Yahoo/Motley Fool

Sun, 01/27/19 - 11:55 am

Pfizer launches China's first pay-for-performance model for cancer

BioCentury

Sat, 01/26/19 - 11:43 am

pay-for-performance

Pfizer, Novartis, Amgen add to 2019 drug price hikes

Biopharma Dive

Fri, 01/25/19 - 11:03 pm

Would Pfizer Shareholders Win With an Acquisition of Amarin?

Motley Fool

Sun, 01/20/19 - 03:26 pm

Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?

Yahoo/Motley Fool

Sun, 01/20/19 - 03:20 pm

Blocking PD-L1 production in mice, UCSF team spotlights preclinical promise of a Pfizer-partnered I/O drug

Endpoints

Thu, 01/17/19 - 12:01 am

immuno-oncology

Pfizer once again takes out the budget ax and lops off 150 R&D staffers and 5 preclinical biosimilar drugs

Endpoints

Mon, 01/14/19 - 11:57 pm

FDA Accepts Pfizer Submissions for Review of Treatment for Rare Amyloid Related Heart Disease

CP Wire

Mon, 01/14/19 - 10:37 am

transthyretin amyloid cardiomyopathy

FDA Accepts Pfizer Submissions for Review of Treatment for Rare Amyloid Related Heart Disease

Mon, 01/14/19 - 10:09 am

transthyretin amyloid cardiomyopathy

Pages